Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026)
Jazz Pharmaceuticals' (JAZZ) quarterly EBT Margin came in at 27.99% in Q1 2026, up 4022.0% year-on-year from 0.68% in Q1 2025, and up 60.85% quarter-over-quarter from 17.4% in Q4 2025.
Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 27.99% for Q1 2026.
- On a quarterly basis, EBT Margin rose 4022.0% year-over-year to 27.99% in Q1 2026; TTM through Mar 2026 was 4.93%, a 1384.0% decrease from a year earlier, with the FY2025 full-year figure at 14.71%, down 2627.0% from the prior year.
- EBT Margin rose to 27.99% in Q1 2026 per JAZZ's latest filing, from 17.4% in the prior quarter.
- Across five years, EBT Margin topped out at 27.99% in Q1 2026 and bottomed at 70.34% in Q2 2025.
- The 5-year median for EBT Margin is 6.08% (2023), against an average of 0.05%.
- Across the five-year window, EBT Margin soared 4105 bps in 2023 and sank 8381 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 34.97% in 2022, then surged by 117 bps to 6.08% in 2023, then jumped by 101 bps to 12.24% in 2024, then soared by 42 bps to 17.4% in 2025, then soared by 61 bps to 27.99% in 2026.
- Per Business Quant, the three latest JAZZ EBT Margin figures stand at 27.99% (Q1 2026), 17.4% (Q4 2025), and 0.8% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 27.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.99% |
| Dec 31, 2025 | 17.40% |
| Sep 30, 2025 | 0.80% |
| Jun 30, 2025 | -70.34% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 19.03% |
| Jun 30, 2024 | 13.47% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | 6.08% |
| Sep 30, 2023 | 10.24% |
| Jun 30, 2023 | 8.54% |
| Mar 31, 2023 | 6.17% |
| Dec 31, 2022 | -34.97% |
| Sep 30, 2022 | -6.39% |
| Jun 30, 2022 | 2.25% |
| Mar 31, 2022 | 0.78% |
| Dec 31, 2021 | -5.00% |
| Sep 30, 2021 | -8.07% |
| Jun 30, 2021 | -18.10% |